These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33189726)

  • 1. Development of magnetic particle-based chemiluminescence immunoassay for measurement of human procalcitonin in serum.
    Liao M; Zheng J; Xu Y; Qiu Y; Xia C; Zhong Z; Liu L; Liu H; Liu R; Liang S
    J Immunol Methods; 2021 Jan; 488():112913. PubMed ID: 33189726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
    Wang G; Wan Y; Lin G; Li Z; Dong Z; Liu T
    J Immunol Methods; 2020; 484-485():112829. PubMed ID: 32673618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic particle-based chemiluminescence immunoassay for serum human heart-type fatty acid binding protein measurement.
    Zheng J; Qiu Y; Xu Y; Quan M; Zhong Z; Wang Q; Wu Y; Zeng X; Xia C; Liu R
    Biotechnol Lett; 2023 Dec; 45(11-12):1431-1440. PubMed ID: 37736778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy for the development of monoclonal antibodies for the determination of human procalcitonin in serum samples.
    Kremmer E; Meyer K; Grässer FA; Flatley A; Kösters M; Luppa PB; Krämer PM
    Anal Bioanal Chem; 2012 Jan; 402(2):989-95. PubMed ID: 22006244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a fluorescent immnunochromatographic assay for the procalcitonin detection of clinical patients in China.
    Wang H; Wang H; Chen S; Dzakah EE; Kang K; Wang J; Wang J
    Clin Chim Acta; 2015 Apr; 444():37-42. PubMed ID: 25659293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay.
    Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP
    Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel homogeneous nanoparticle-based assay for sensitive procalcitonin detection of ultra low-volume serum samples.
    Li P; Chen Z; Liu B; Li K; Wang H; Lin L; He L; Wei J; Liu T
    Int J Nanomedicine; 2018; 13():5395-5404. PubMed ID: 30254442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein.
    Xu Y; Xia C; Zeng X; Qiu Y; Liao M; Jiang Q; Quan M; Liu R
    J Virol Methods; 2022 Apr; 302():114486. PubMed ID: 35108595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A semi-quantitative rapid multi-range gradient lateral flow immunoassay for procalcitonin.
    Serebrennikova KV; Samsonova JV; Osipov AP
    Mikrochim Acta; 2019 Jun; 186(7):423. PubMed ID: 31187212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the concentration of procalcitonin using a magnetic particles-based chemiluminescence assay for the clinical diagnosis of sepsis.
    Qi S; Li Q; Rao W; Liu X; Yin L; Zhang H
    Anal Sci; 2013; 29(8):805-10. PubMed ID: 23934561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O; Salvagno GL; Gelati M; Lippi G
    Pract Lab Med; 2016 Dec; 6():8-13. PubMed ID: 28856208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM; Bargnoux AS; Montagnon V; Kuster N; Badiou S; Cristol JP
    Scand J Clin Lab Invest; 2020 Nov; 80(7):541-545. PubMed ID: 33124916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As a Novel Procalcitonin Assay is Architect B∙R∙A∙H∙M∙S PCT; Comparison of Two Commercial Systems.
    Aydemir Ö; Karakeçe E; Köroğlu M; Aydemir Y; Terzi HA; Erkorkmaz Ü; Altindiş M
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Lo Cascio C; Demonte D; Faggian D; Plebani M
    Clin Chem Lab Med; 2019 Dec; 58(1):77-84. PubMed ID: 31539351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of bacterial infection using procalcitonin].
    Takajo I; Okayama A
    Rinsho Byori; 2010 May; 58(5):517-22. PubMed ID: 20560461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of new rat monoclonal antibodies for procalcitonin.
    Krämer PM; Gouzy MF; Kess M; Kleinschmidt U; Kremmer E
    Anal Bioanal Chem; 2008 Oct; 392(4):727-36. PubMed ID: 18712365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Procalcitonin Assay on the Abbott Architect i1000.
    Pagaduan JV; Tam E; Devaraj S
    J Appl Lab Med; 2019 May; 3(6):936-942. PubMed ID: 31639685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.